Key result
The diffuse alveolar damage (DAD) pattern on CT was associated with higher mortality in patients with severe drug-induced interstitial lung disease compared to non-DAD patterns.
Why the study?
The frequency and prognostic factors of severe drug-induced interstitial lung disease caused by antineoplastic drugs across all cancer types and drug classes required investigation.
Cohort (n=19,132)
No
Severe drug-induced interstitial lung disease occurs in 0.62% of patients receiving antineoplastic therapy, with thoracic cancer, pre-existing ILD, poor performance status, and DAD pattern on CT predicting high mortality.
Answers are grounded in this paper and cite their sources.
Severe DILD incidence peaks in thoracic cancers with DAD pattern tied to higher mortality; leaves open prospective validation of risk factors before guiding monitoring.
PURPOSE: Investigate the frequency and prognostic factors of severe drug-induced interstitial lung disease (DILD) caused by antineoplastic drugs regardless of cancer types or type of drugs. METHODS: From 2014 to 2018, we reviewed patients with a history of antineoplastic agents administration in the real-world database of our hospital's electronic medical record and extracted patients who experienced "severe" DILD, requiring hospitalization with treatment or developed during hospitalization and required treatment. We collected patients' backgrounds, clinical and radiological features, laboratory data, treatment, and survival outcomes. RESULTS: 19,132 cancer patients received antineoplastic drug therapy during the study period, and 120 (0.62%) experienced severe DILD. The incidence of severe DILD in patients with thoracic cancer was highest among the patients included in this analysis (2.52% vs. 0.34% other cancers). Diffuse alveolar damage (DAD) pattern on CT was associated with higher mortality in patients with severe DILD compared with non-DAD pattern (hazard ratio [HR], 11.24; 95% CI, 4.82-26.2). Multivariate analysis revealed that the DAD pattern at diagnosis as severe DILD (HR, 3.59; 95% CI, 1.17-11.03), concurrent/previous interstitial lung disease (HR, 3.20; 95% CI, 1.27-8.10), and ECOG performance status of 2-4 (HR, 3.81; 95% CI, 1.10-13.17) were independent risk factors for mortality in patients with severe DILD. CONCLUSIONS: The frequency of severe DILD was highest in patients with thoracic cancer. The DAD pattern was associated with a poor outcome. From the perspective of DILD, special attention should be paid when administering antineoplastic agents to patients with thoracic cancer.
No takes yet. Share an insight, caveat, or question.
Kaku et al. (2022) conducted a cohort in Cancer (patients receiving antineoplastic drug therapy) (n=19,132). Diffuse alveolar damage (DAD) pattern on CT vs. Non-DAD pattern was evaluated on Mortality (HR 11.24, 95% CI 4.82-26.2, p=<0.01). The diffuse alveolar damage (DAD) pattern on CT was associated with higher mortality in patients with severe drug-induced interstitial lung disease compared to non-DAD patterns.
Synapse has enriched 10 related papers. Consider them for comparative context: